KRTX   $329.83  0.02% Market Closed

Karuna Therapeutics Inc
Total Cash 1.26B
totalCashPerShare 33.103
EBITDA -492.49M
Total Debt 16.69M
quickRatio 18.706
currentRatio 19.306
Total Revenue 654.00K
debtToEquity 1.331
Revenue/Share 0.018
ROA -0.24714
ROE -0.36436
grossProfits
freeCashflow -223.64M
operatingCashflow -385.82M
earningsGrowth
revenueGrowth -1.0
grossMargins 1.0
ebitdaMargins 0.0
operatingMargins -755.6407
profitMargins 0.0
enterpriseValue 11.34B
forwardPE -36.48562
floatShares 36.27M
sharesOutstanding 38.20M
sharesShort 1.97M
sharesShortPriorMonth 1.69M
dateShortInterest
sharesPercentSharesOut 0.05%
heldPercentInsiders 0.05%
heldPercentInstitutions 0.86%
Short Ratio help_outline 3.60%
shortPercentOfFloat 0.06%
impliedSharesOutstanding
bookValue 32.939
Price To Book help_outline 10.01
earningsQuarterlyGrowth
netIncomeToCommon -433.68M
trailingEps -11.74%
forwardEps -9.04%
enterpriseToEbitda -23.02
lastDividendValue
lastDividendDate
currentQuarterEstimate -3.06 1Q 2024
institutionsCount 429
lastUpdated April 1, 2024, 2:27 p.m.